Biomedicines (Feb 2022)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role

  • Haripriya Gupta,
  • Byeong-Hyun Min,
  • Raja Ganesan,
  • Yoseph Asmelash Gebru,
  • Satya Priya Sharma,
  • Eunju Park,
  • Sung-Min Won,
  • Jin-Ju Jeong,
  • Su-Been Lee,
  • Min-Gi Cha,
  • Goo-Hyun Kwon,
  • Min-Kyo Jeong,
  • Ji-Ye Hyun,
  • Jung-A. Eom,
  • Hee-Jin Park,
  • Sang-Jun Yoon,
  • Mi-Ran Choi,
  • Dong-Joon Kim,
  • Ki-Tae Suk

DOI
https://doi.org/10.3390/biomedicines10030550
Journal volume & issue
Vol. 10, no. 3
p. 550

Abstract

Read online

Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty degenerative disorders in the liver, including simple steatosis, steatohepatitis and fibrosis. The fundamental pathophysiology of NAFLD is complex and multifactor-driven. In addition to viruses, metabolic syndrome and alcohol, evidence has recently indicated that the microbiome is related to the development and progression of NAFLD. In this review, we summarize the possible microbiota-based therapeutic approaches and highlight the importance of establishing the diagnosis of NAFLD through the different spectra of the disease via the gut–liver axis.

Keywords